🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Elisa Aquilanti

Broad Institute

ORCID: 0000-0002-1343-5017

Also affiliated with Harvard University, Center for Neuro-Oncology, Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma”.

Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma

Neuro-Oncology(2025)10.1093/neuonc/noaf287

N/A

0.241DataRank · unranked

4 citations

Elisa Aquilanti, Julie J. Miller, Zhou Lan, Aleksandra B Lasica, Isabel Arrillaga‐Romany +20 more

Data from Correlation Analysis between Single-Nucleotide Polymorphism and Expression Arrays in Gliomas Identifies Potentially Relevant Target Genes

(2023)10.1158/0008-5472.c.6499881.v1

N/A

0DataRank · unranked

0 citations

Svetlana Kotliarova, Nurdina Charong, Aiguo Li, Jennifer Walling, Elisa Aquilanti +6 more

Novel Therapies for Primary Central Nervous System Lymphomas

Current Neurology and Neuroscience Reports(2024)10.1007/s11910-024-01376-5

N/A

0DataRank · unranked

5 citations

Elizabeth Herrity, Lakshmi Nayak, Elisa Aquilanti